- In April 2023, the Biomedical Advanced Research and Development Authority (BARDA) partnered with Aptitude Medical Systems, Inc. to accelerate the development of molecular diagnostic tests for COVID-19. These Metrix tests use saliva samples as clinical specimens, enhancing accessibility to high-quality diagnostics
- In April 2021, Quidel Corporation entered a distribution agreement with McKesson Corporation to expand the availability of at-home COVID-19 testing services, boosting the market potential for saliva-based screening tests
- In February 2021, George Mason University in Fairfax began COVID-19 testing using Fluidigm Corporation’s Advanta Dx SARS-CoV-2 RT-PCR Assay on the Fluidigm Biomark HD system
